Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


18.09.2017

1 AIDS Res Hum Retroviruses
1 BMJ
2 Clin Infect Dis
1 Infect Immun
2 J Immunol
3 J Infect Dis
2 J Virol
2 Lancet
2 Lancet Infect Dis
1 N Engl J Med
1 PLoS Comput Biol
3 PLoS One
24 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS Res Hum Retroviruses

  1. FLEURY HJ, Tumiotto C, Bellecave P, Recordon-Pinson P, et al
    Therapeutic vaccine against HIV, viral variability, CTL epitopes and genetics of patients.
    AIDS Res Hum Retroviruses. 2017.
    PubMed     Text format     Abstract available


    BMJ

  2. DOSHI P
    The problem with US website for collecting adverse events after vaccination is resolved.
    BMJ. 2017;358:j4164.
    PubMed     Text format    


    Clin Infect Dis

  3. KIM L, Rha B, Abramson JS, Anderson LJ, et al
    Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines.
    Clin Infect Dis. 2017;65:1020-1025.
    PubMed     Text format     Abstract available

  4. SCHROEDER MR, Chancey ST, Thomas S, Kuo WH, et al
    A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance
    Clin Infect Dis. 2017;65:990-998.
    PubMed     Text format     Abstract available


    Infect Immun

  5. SEVASTSYANOVICH YR, Withers DR, Marriott CL, Morris FC, et al
    Antigen localisation influences the magnitude and kinetics of the endogenous adaptive immune response to recombinant Salmonella vaccines.
    Infect Immun. 2017 Sep 11. pii: IAI.00593-17. doi: 10.1128/IAI.00593.
    PubMed     Text format     Abstract available


    J Immunol

  6. BETANCOURT D, de Queiroz NM, Xia T, Ahn J, et al
    Cutting Edge: Innate Immune Augmenting Vesicular Stomatitis Virus Expressing Zika Virus Proteins Confers Protective Immunity.
    J Immunol. 2017 Mar 13. pii: 1602180. doi: 10.4049/jimmunol.1602180.
    PubMed     Text format     Abstract available

  7. NORDSTROM T, Pandey M, Calcutt A, Powell J, et al
    Enhancing Vaccine Efficacy by Engineering a Complex Synthetic Peptide To Become a Super Immunogen.
    J Immunol. 2017 Sep 13. pii: ji1700836. doi: 10.4049/jimmunol.1700836.
    PubMed     Text format     Abstract available


    J Infect Dis

  8. ZIPURSKY S, Vandelaer J, Brooks A, Dietz V, et al
    Polio Endgame: Lessons Learned From the Immunization Systems Management Group.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  9. PATEL M, Cochi S
    Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  10. PEDREIRA C, Thrush E, Jauregui B
    Systematization of the Introduction of IPV and Switch from tOPV to bOPV in the Americas.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


    J Virol

  11. RYERSON MR, Richards MM, Kvansakul M, Hawkins CJ, et al
    Vaccinia virus encodes a novel inhibitor of apoptosis that associates with the apoptosome.
    J Virol. 2017 Sep 13. pii: JVI.01385-17. doi: 10.1128/JVI.01385.
    PubMed     Text format     Abstract available

  12. SAUERMANN U, Radaelli A, Stolte-Leeb N, Raue K, et al
    Vector order determines protection against pathogenic simian immunodeficiency virus infection in a triple component vaccine by balancing CD4+ and CD8+ T-cell responses.
    J Virol. 2017 Sep 13. pii: JVI.01120-17. doi: 10.1128/JVI.01120.
    PubMed     Text format     Abstract available


    Lancet

  13. DENNY L
    Nine-valent human papillomavirus vaccine: great science, but will it save lives?
    Lancet. 2017 Sep 5. pii: S0140-6736(17)32144.
    PubMed     Text format    

  14. HUH WK, Joura EA, Giuliano AR, Iversen OE, et al
    Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
    Lancet. 2017 Sep 5. pii: S0140-6736(17)31821.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  15. YEUNG KHT, Duclos P, Nelson EAS, Hutubessy RCW, et al
    An update of the global burden of pertussis in children younger than 5 years: a modelling study.
    Lancet Infect Dis. 2017;17:974-980.
    PubMed     Text format     Abstract available

  16. STEINHOFF MC, Katz J, Englund JA, Khatry SK, et al
    Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial.
    Lancet Infect Dis. 2017 May 15. pii: S1473-3099(17)30252.
    PubMed     Text format     Abstract available


    N Engl J Med

  17. GLICKMAN G, Harrison E, Dobkins K
    Vaccination Rates among Younger Siblings of Children with Autism.
    N Engl J Med. 2017;377:1099-1101.
    PubMed     Text format    


    PLoS Comput Biol

  18. HOLME P, Litvak N
    Cost-efficient vaccination protocols for network epidemiology.
    PLoS Comput Biol. 2017;13:e1005696.
    PubMed     Text format     Abstract available


    PLoS One

  19. ALAM S, Chan C, Qiu X, Shannon I, et al
    Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.
    PLoS One. 2017;12:e0176407.
    PubMed     Text format     Abstract available

  20. JIA B, McNeil LK, Dupont CD, Tsioris K, et al
    Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires.
    PLoS One. 2017;12:e0183738.
    PubMed     Text format     Abstract available

  21. KANEKO M, Takanashi S, Thongprachum A, Hanaoka N, et al
    Identification of vaccine-derived rotavirus strains in children with acute gastroenteritis in Japan, 2012-2015.
    PLoS One. 2017;12:e0184067.
    PubMed     Text format     Abstract available


    Vaccine

  22. LIN X, Rodgers L, Zhu L, Stokley S, et al
    Human papillomavirus vaccination coverage using two-dose or three-dose schedule criteria.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)31200.
    PubMed     Text format     Abstract available

  23. WALLDORF JA, Cloessner EA, Hyde TB, MacNeil A, et al
    Considerations for use of Ebola vaccine during an emergency response.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)31156.
    PubMed     Text format     Abstract available

  24. SUNDARAMURTHI JC, Ashokkumar M, Swaminathan S, Hanna LE, et al
    HLA based selection of epitopes offers a potential window of opportunity for vaccine design against HIV.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31168.
    PubMed     Text format     Abstract available

  25. ADAMSON PJ, Al Kindi MA, Wang JJ, Colella AD, et al
    Proteomic analysis of influenza haemagglutinin-specific antibodies following vaccination reveals convergent immunoglobulin variable region signatures.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31151.
    PubMed     Text format     Abstract available

  26. NOWAK GJ, Shen AK, Schwartz JL
    Using campaigns to improve perceptions of the value of adult vaccination in the United States: Health communication considerations and insights.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31162.
    PubMed     Text format     Abstract available

  27. WOO EJ, Moro PL, Cano M, Jankosky C, et al
    Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31135.
    PubMed     Text format     Abstract available

  28. WONG LP, Alias H, Hassan J, AbuBakar S, et al
    Attitudes towards Zika screening and vaccination acceptability among pregnant women in Malaysia.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31172.
    PubMed     Text format     Abstract available

  29. SANTOS JJS, Obadan AO, Garcia SC, Carnaccini S, et al
    Short- and long-term protective efficacy against clade 2.3.4.4 H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31157.
    PubMed     Text format     Abstract available

  30. VICKERS ER, McClure DL, Naleway AL, Jacobsen SJ, et al
    Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31186.
    PubMed     Text format     Abstract available

  31. LUZ PM, Johnson RE, Brown HE
    Workplace availability, risk group and perceived barriers predictive of 2016-17 influenza vaccine uptake in the United States: A cross-sectional study.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)31178.
    PubMed     Text format     Abstract available

  32. KROISS SJ, Famulare M, Lyons H, McCarthy KA, et al
    Evaluating cessation of the type 2 oral polio vaccine by modeling pre- and post-cessation detection rates.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)31136.
    PubMed     Text format     Abstract available

  33. MENDEL-VAN ALSTYNE JA, Nowak GJ, Aikin AL
    What is 'confidence' and what could affect it?: A qualitative study of mothers who are hesitant about vaccines.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31222.
    PubMed     Text format     Abstract available

  34. GIEL-MOLONEY M, Rumyantsev AA, David F, Figueiredo M, et al
    A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31153.
    PubMed     Text format     Abstract available

  35. ISLAM S, Mohn KG, Krammer F, Sanne M, et al
    Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31132.
    PubMed     Text format     Abstract available

  36. VORNO T, Lutsar K, Uuskula A, Padrik L, et al
    Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31183.
    PubMed     Text format     Abstract available

  37. KAILASHIYA C, Sharma HB, Kailashiya J
    Telomerase based anticancer immunotherapy and vaccines approaches.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31227.
    PubMed     Text format     Abstract available

  38. SOW SO, Steele AD, Mwenda JM, Armah GE, et al
    Reaching every child with rotavirus vaccine: Report from the 10th African rotavirus symposium held in Bamako, Mali.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31184.
    PubMed     Text format     Abstract available

  39. WILLAME C, Henry O, Lin L, Vetter V, et al
    Pain caused by measles, mumps, and rubella vaccines: A systematic literature review.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31166.
    PubMed     Text format     Abstract available

  40. WICHMANN O, Vannice K, Asturias EJ, de Albuquerque Luna EJ, et al
    Live-attenuated tetravalent dengue vaccines: The needs and challenges of post-licensure evaluation of vaccine safety and effectiveness.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31164.
    PubMed     Text format     Abstract available

  41. LEINO T, Baum U, Scott P, Ollgren J, et al
    Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31140.
    PubMed     Text format     Abstract available

  42. NEUZIL KM, Bresee JS, de la Hoz F, Johansen K, et al
    Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31188.
    PubMed     Text format     Abstract available

  43. SHAPIRO GK, Guichon J, Kelaher M
    Canadian school-based HPV vaccine programs and policy considerations.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31005.
    PubMed     Text format     Abstract available

  44. RAVIOTTA JM, Smith KJ, DePasse J, Brown ST, et al
    Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)30977.
    PubMed     Text format     Abstract available

  45. ELDEMERY F, Joiner KS, Toro H, van Santen VL, et al
    Protection against infectious bronchitis virus by spike ectodomain subunit vaccine.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31229.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: